| Year |
Citation |
Score |
| 2017 |
Pike JW, Meyer MB, Lee SM, Onal M, Benkusky NA. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights. The Journal of Clinical Investigation. PMID 28240603 DOI: 10.1172/JCI88887 |
0.306 |
|
| 2015 |
Kaneko I, Sabir MS, Dussik CM, Whitfield GK, Karrys A, Hsieh JC, Haussler MR, Meyer MB, Pike JW, Jurutka PW. 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26071405 DOI: 10.1096/Fj.14-269811 |
0.303 |
|
| 2012 |
Pike JW, Meyer MB, Bishop KA. Regulation of target gene expression by the vitamin D receptor - an update on mechanisms. Reviews in Endocrine & Metabolic Disorders. 13: 45-55. PMID 21870057 DOI: 10.1007/s11154-011-9198-9 |
0.303 |
|
| 2011 |
Kriebitzsch C, Verlinden L, Eelen G, van Schoor NM, Swart K, Lips P, Meyer MB, Pike JW, Boonen S, Carlberg C, Vitvitsky V, Bouillon R, Banerjee R, Verstuyf A. 1,25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2991-3000. PMID 21898591 DOI: 10.1002/Jbmr.493 |
0.301 |
|
| 2010 |
Zella LA, Meyer MB, Nerenz RD, Lee SM, Martowicz ML, Pike JW. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Molecular Endocrinology (Baltimore, Md.). 24: 128-47. PMID 19897601 DOI: 10.1210/Me.2009-0140 |
0.305 |
|
| 2009 |
Zella LA, Meyer MB, Nerenz RD, Pike JW. The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a selective and prolonged induction of intestinal calcium-regulating genes. Endocrinology. 150: 3448-56. PMID 19423758 DOI: 10.1210/en.2009-0113 |
0.305 |
|
| 2007 |
Zella LA, Kim S, Shevde NK, Pike JW. Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. The Journal of Steroid Biochemistry and Molecular Biology. 103: 435-9. PMID 17218097 DOI: 10.1016/j.jsbmb.2006.12.019 |
0.304 |
|
| 2006 |
Zella LA, Kim S, Shevde NK, Pike JW. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Molecular Endocrinology (Baltimore, Md.). 20: 1231-47. PMID 16497728 DOI: 10.1210/me.2006-0015 |
0.303 |
|
| 2003 |
Yamamoto H, Shevde NK, Warrier A, Plum LA, DeLuca HF, Pike JW. 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. The Journal of Biological Chemistry. 278: 31756-65. PMID 12796488 DOI: 10.1074/Jbc.M304737200 |
0.314 |
|
| 1995 |
Imai Y, Pike JW, Koeffler HP. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Leukemia Research. 19: 147-58. PMID 7700077 DOI: 10.1016/0145-2126(94)00127-V |
0.305 |
|
| 1994 |
Pavlin D, Bedalov A, Kronenberg MS, Kream BE, Rowe DW, Smith CL, Pike JW, Lichtler AC. Analysis of regulatory regions in the COL1A1 gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression in osteoblastic cells. Journal of Cellular Biochemistry. 56: 490-501. PMID 7890807 DOI: 10.1002/Jcb.240560409 |
0.301 |
|
| 1993 |
Santiso-Mere D, Sone T, Hilliard GM, Pike JW, McDonnell DP. Positive regulation of the vitamin D receptor by its cognate ligand in heterologous expression systems. Molecular Endocrinology (Baltimore, Md.). 7: 833-9. PMID 8413308 DOI: 10.1210/Mend.7.7.8413308 |
0.309 |
|
| 1991 |
Pike JW. Vitamin D3 receptors: Structure and function in transcription Annual Review of Nutrition. 11: 189-216. PMID 1654066 DOI: 10.1146/ANNUREV.NU.11.070191.001201 |
0.316 |
|
| Show low-probability matches. |